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INTRODUCTION:  Gastrointestinal  stromal  tumors  (GISTs)  are  the  most  common  gastrointestinal  tract  (GIT)
tumors  of mesenchymal  origin.  GISTs  tend to arise  with  a higher  frequency  in  the  stomach  and  the  small
intestine.  GISTs  that  originate  from  outside  of  the  GIT  are  deﬁned  as  extra-gastrointestinal  stromal  tumors
(EGISTs).  Among  them  pancreatic  EGISTs  are  very  rare.
CASE  PRESENTATION:  A  30 years  old  male  patient  presented  with  abdominal  pain.  Triphasic  abdomi-
nal  computed  tomography  scan  with  contrast  revealed  large  well  deﬁned  mass  at the  pancreatic  tail,
about  12 ×  11.6  cm.  Laparoscopic  distal  pancreatectomy  and  splenectomy  was  performed.  Postoperative
pathological  examination  revealed  positive  CD 117  and  Dog 1 conﬁrming  the  diagnosis  of EGISTs.
DISCUSSION:  GIST  is a rare  mesenchymal  tumor.  EGISTs  arising  in the pancreas  are  extremely  rare,  about,
5%  of EGISTs.  Its  origin  remains  controversial.  Some  authors  believe  that  GISTs  and  EGISTs  arise  from  the
common  cell  origin  of  interstitial  cells of  Cajal.  Others  suggest  that  EGISTs  are  at  the  beginning,  mural
GISTs  with  extensive  extramural  growth,  resulting  in  later  on,  loss of their connection  with  the  GIT wall.
CONCLUSION:  We  report a rare case of  large  pancreatic  tail  EGIST,  which  was  resected,  safely  and  effec-
tively by  laparoscopic  approach.
© 2016  Published  by  Elsevier  Ltd on  behalf  of  IJS  Publishing  Group  Ltd.  This  is  an  open  access  article
he  CCunder  t
. Introduction
GISTs are rare mesenchymal tumors that can arise in any part of
he GIT. Most of these tumors arise in the stomach and small intes-
ine [1]. It should be noted that, GISTs that originate from outside of
he GIT, are deﬁned as EGISTs and are usually arise from omentum,
esentery and retroperitoneam, adjacent, but separate from the
tomach and the intestine [2]. EGISTs that arise from the pancreas
re extremely rare, and only 30 cases have been reported in the
iterature to date [3].
. Case presentation
At our outpatient clinic, 30 years old male patient presented
ith abdominal pain of 2 weeks duration associated with anorexia
nd weight loss. The body mass index of the patient was 26.7 kg/m2nd no associated co-morbidity. Physical examination revealed no
peciﬁc ﬁnding. Routine laboratory investigations were within nor-
al  limit.
∗ Corresponding author.
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ttp://dx.doi.org/10.1016/j.ijscr.2016.08.019
210-2612/© 2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This i
rg/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abdominal ultrasonography (US) showed large mass
15 × 14 × 12 cm at pancreatic tail. Triphasic abdominal CT with
contrast revealed large well deﬁned mass at pancreatic tail, about
12 × 11.6 cm,  partially solid/cystic, compressing the pancreatic
tissue and the splenic vein was seen stretched on outer surface of
the mass (Fig. 1).
3. The procedure
Laparoscopic distal pancreatectomy and splenectomy was per-
formed. At laparoscopic assessment, large cystic mass about 10 cm
in size, at the tail of the pancreas, adherent to splenic vein
but not attached to the surrounding organs as stomach. No
ascitis, no hepatic focal lesions and no evidence of peritoneal
nodules.
Firstly, opening of the lesser sac along the greater curvature of
stomach was  done for exposing the pancreatic mass (Fig. 2). Trial
of dissection along the mass to do localized resection with safety
margin but the mass was  adherent to splenic vein. So, the decision
was to do distal pancreatectomy and splenectomy.Double ligation and clipping of splenic artery was performed
(Fig. 3). Transection of the pancreas using laparoscopic Endo GIA
stapler 60 mm  (Fig. 4). Mobilization of the spleen by division of
leino-renal and spleno-colic ligaments.
s an open access article under the CC BY-NC-ND license (http://creativecommons.
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Fig. 1. Triphasic abdominal CT with contrast, (coronal and axial view) revealed large well deﬁned, partially solid/cystic mass at pancreatic tail.
Fig. 2. Opening of the lesser sac and exposure of the pancreatic EGIST mass.
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aFig. 3. Ligation and clipping of the splenic artery.
Extraction of specimen enbloc through pfennestiel incision was
one with good haemostasis and drain at splenic bed. Finally, clo-
ure of the incision and abdominal ports.
. Histopathological examination
Macroscopic examination showed spleen measuring
2 × 8 × 3 cm,  part of pancreas with attached cystic mass measur-
ng 12 × 11 × 3 cm.  The mass was partially cystic, partially solid.
issection of surrounding fat revealed nine LNs with ﬁrm greyish
hite cut surface.
Microscopically, the tumor was formed of spindle cell prolifer-
tion in fasicular pattern with oval shaped nuclei (Fig. 5A&B). TheFig. 4. Transection of the pancreas using laparoscopic Endo GIA stapler.
mitotic count was 6 mitoses/50 High Power Fields. Immunohisto-
chemical staining revealed positive immunoreactivity of the tumor
cells for CD117 (Fig. 5C) and DOG-1 (Fig. 5D) while smooth muscle
actin, S100 protein, CD10 and CD56 were negative. So, the diagno-
sis was  high risk pancreatic GIST with free safety margin and all
dissected nine lymph nodes.
5. Post-operative
The patient had oral feeding at 2nd post-operative day (POD).
Post-operative laboratory evaluation as blood sugar and serum
amylase was  within normal range. Drain was removed and the
patient was  discharged at 3rd POD without any complication.
6. Follow up
The patient was  referred to oncology department and recieved
imitinab therapy in a dose of 400 mg  twice daily. There was no local
or systemic recurrence detected during the three months follow-up
examination.
7. Discussion
GISTs are the most common mesenchymal tumors of the GIT
[4]. It is believed that these tumors originate from interstitial cells
of Cajal (ICCs) [4]. These tumors may  present at any site in the GIT
where there are ICCs but, the most common locations are stomach,
small intestine and colon [5]. EGISTs are stromal tumors that origi-
nating from outside the GIT and show no connection to the wall or
the peritoneal surface of the GIT [6].
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Fig. 5. Histomicrographs of GIST. A, The neoplastic proliferation and the adjacent panreaticacini (blue arrow) can be seen (H&E x200). B, The tumor is formed of spindle cell
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froliferation in fasicular pattern with oval shaped nuclei (H&E x200). C, The neopla
howed positive cytoplasmic staining for DOG1 (IHC x400). (For interpretation of t
his  article.)
It is reported that, EGISTs are extremely rare, represent 5%-10%
f all GISTs [7,8]. EGISTs are frequently located in the omentum,
esentery or retroperitoneum [9]. EGISTs arising in the pancreas
re extremely rare, about, 5% of EGISTs [10].
The clinical presentation of pancreatic EGISTs is variable,
epending on the location and size of the tumors in the pancreas
10,11]. The tumor may  be discovered accidently [11]. Radiologi-
al evaluation of pancreatic tumors is done by abdominal CT, US,
nd endoscopic US, and aid in determining tumor localization, size,
nvasion of surrounding organs, and distant metastases; however,
ost of them are non-diagnostic [12].
The diagnosis of GIST is based mainly on histopathological,
mmunohistochemical, and molecular features. Histopathologi-
ally, GISTs are classiﬁed into three main types, spindle, epithelioid,
r mixed type. Most pancreatic EGISTs consist of spindle cells [8].
It should be noted that, the most selective immunohistochemi-
al markers of GISTs is the expression of the c-Kit receptor tyrosine
inase (CD117 antigen) in 95% of GISTs. It was reported that EGISTs
how similar KIT mutations of typical GISTs suggesting that these
umors have a similar origin [13].
However, the origin of EGISTs still remains controversial. Some
uthors believe that GISTs and EGISTs arise from the common cell
rigin of ICCs, which may  account for their growth within and out-
ide the GIT .Other explanation suggests that EGISTs are in fact
ural GISTs with extensive extramural growth, resulting in lastly,
oss of their connection with the GIT [14].
Surgical resection is believed to be the primary preferred line of
reatment of pancreatic EGIST [1]. The aim of surgical resection of
ancreatic EGIST is to achieve complete resection with clear safety
argins [8,15].
Selection the optimal type of surgical resection depends on pan-reatic EGIST location. Pancreatecoduodenectomy is the optimal
reatment for pancreatic head tumors, while distal pancreatectomy
or pancreatic tail tumors [8]. Routine lymph node dissection is notells showed positive cytoplasmic staining for CD117 (IHCx200). D, The tumor cells
erences to colour in this ﬁgure legend, the reader is referred to the web version of
indicated in pancreatic EGIST cases because of rare regional lymph
node metastases [11].
Imatinib, which is an inhibitor of the tyrosine kinase activity of
C-Kit, has been added as a line of treatment of GISTs [16]. Neoadju-
vant and adjuvant therapy with imatinib has been shown to reduce
the risk of recurrence and improve the survival [17]. Imatinib can be
used as neoadjuvant therapy, for large size GISTs to reduce tumor
size, increase the rate of complete resection of the tumor, and help
to improve prognosis [8,18].
Laparoscopic distal pancreatectomy is now performed more fre-
quently in the surgical resection of benign and even malignant
tumors in the body and tail of the pancreas [19]. Many studies
have reported that, Laparoscopic distal pancreatectomy is associ-
ated with decreased intraoperative blood loss, shorter hospital stay
and less morbidity compared with open distal pancreatectomy [20].
8. Conclusion
We report a case of large pancreatic EGIST, which is considered
a rare tumor. Laparoscopic distal pancreatectomy can be safely and
effectively performed in the curative surgical resection of pancre-
atic EGIST.
Consent
Written informed consent was obtained from the patient for
publication of this case report.Conﬂict of interest
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